Completed
Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon
NCT00419419
- Conditions
- Autoimmune Diseases, Cardiovascular Diseases, Connective Tissue Diseases, +14 more
- Locations
-
- Standford Medical School Stanford, California, United States
- University of Connecticut Farmington, Connecticut, United States
- Georgetown University Medical Center Washington D.C., District of Columbia, United States
- Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States